Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography
Summary
This protocol compares use of single nucleotide polymorphism panels to common risk assessment models. Women undergoing screening mammography or breast biopsy due to BIRADS Category 4 lesion will be asked to provide buccal swabs and health information used to complete each risk model. These risk models will be compared to see whether either improves the positive predictive value of breast biopsy for BIRADS4 lesions. Subjects undergoing biopsy will be followed to examine cancer outcomes.
Description
Calculating the risk that a woman will develop breast cancer in her lifetime can lead to decreased mortality rates as a result of increased screening and prevention methods when a person is known to be at high risk. Though there are several risk assessment models that are commonly used, it is important to continue to improve the process of calculating risk. Several genetic markers have been noted to potentially indicate risk of developing breast cancer. New tests, called SNP panels, can detect some of these genetic markers. This study aims to use both these SNP panels and the commonly used risk models to calculate risk and examine outcomes in women coming in to do screening mammography. This study will enroll women between the ages of 40-65 who are undergoing screening mammography (n=600), in addition to women with BIRADS category 4 mammogram readings who are about to undergo biopsy (n=600), all with no personal history of breast or ovarian cancer, ductal carcinoma in situ (DCIS), mantle radiation, or known BRCA 1/2/mutation in self or family members. The participants will only be expected rto provide consent, swabs of the inside of the cheek of her mouth, and baseline questionnaire answers that will allow for a risk assessment to be performed.
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Conditions
Mammography
Location
Abramson Cancer Center of the University of Pennsylvania
Philadelphia
Pennsylvania
United States
19104
Status
Recruiting
Source
Abramson Cancer Center of the University of Pennsylvania
Results (where available)
Links
- Source: http://clinicaltrials.gov/show/NCT01124019
- Information obtained from ClinicalTrials.gov on July 15, 2010
Medical and Biotech [MESH] Definitions
Mammography
Radiographic examination of the breast.
Clinical Trials
RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective...
Computed Tomography Laser Mammography Breast Imaging Device
The purpose of this study is to evaluate the sensitivity and specificity of the CTLM system when used adjunctively with mammography compared to mammography alone in the heterogeneously and...
Visibility of Lesion Characteristics With Phase Contrast Mammography
To determine if diagnostic phase contrast mammography (PCM) will provide improved image detail in assessing lesion characteristics when compared to diagnostic x-ray mammography (XM).
The purpose of this study is to determine whether addition of automated whole breast ultrasound to the usual screening mammography in a population of asymptomatic women with mammographical...
Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD)
The objective of this study is to collect an image library of diagnostic digital mammograms using the Carestream CR mammography system from patients who have histological-conformed breast...
PubMed Articles
Mammography and the risk of thyroid cancer.
OBJECTIVE: The purpose of this article is to discuss recent media reports that have suggested a link between mammography and increased incidence of thyroid cancer in women. Those reports have caused m...
Perspectives of the digital mammography platform.
In Europe one out of every nine women suffers from breast cancer during her lifetime. Since the introduction of mammography screening programs more breast cancers are being diagnosed when they are sti...
Breast cancer screening using mammography is one of the few screening interventions that have been assessed in several large randomized controlled studies (RCTs). Results from eight RCTs are available...
The Value of Mammography Within 1 Year of Conservative Surgery for Breast Cancer.
INTRODUCTION: Guidelines for screening mammography have been established by numerous medical societies. Guidelines have not been established for follow-up mammography for patients who have been treate...
